dc.contributorGrupo de Investigaciones Microbiológicas - UR (GIMUR)
dc.creatorRios-Chaparro, Dora-Ines
dc.creatorHerrera, Giovanny
dc.creatorSoto-De Leon, Sara C.
dc.creatorBirchenall, Claudia
dc.creatorPinilla, Darío
dc.creatorPardo-Oviedo, Juan Mauricio
dc.creatorJosa, Diego
dc.creatorPatarroyo, Manuel A.
dc.creatorRamírez, Juan David
dc.date.accessioned2020-03-30T22:49:44Z
dc.date.accessioned2022-09-22T14:06:28Z
dc.date.available2020-03-30T22:49:44Z
dc.date.available2022-09-22T14:06:28Z
dc.date.created2020-03-30T22:49:44Z
dc.date.issued2018
dc.identifier1664-302X
dc.identifierhttps://repository.urosario.edu.co/handle/10336/21306
dc.identifierhttps://doi.org/10.3389/fmicb.2018.00074
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3435874
dc.description.abstractClostridium difficile (CD) produces antibiotic associated diarrhea and leads to a broad range of diseases. The source of CD infection (CDI) acquisition and toxigenic profile are factors determining the impact of CD. This study aimed at detecting healthcare facility onset- (HCFO) and community-onset (CO) CDI and describing their toxigenic profiles in Bogotá, Colombia. A total of 217 fecal samples from patients suffering diarrhea were simultaneously submitted to two CDI detection strategies: (i) in vitro culture using selective chromogenic medium (SCM; chromID, bioMérieux), followed verification by colony screening (VCS), and (ii) molecular detection targeting constitutive genes, using two conventional PCR tests (conv. PCR) (conv.16S y conv.gdh) and a quantitative test (qPCR.16s). The CD toxigenic profile identified by any molecular test was described using 6 tests independently for describing PaLoc and CdtLoc organization. High overall CDI frequencies were found by both SCM (52.1%) and conv. PCR (45.6% for conv.16S and 42.4% for conv.gdh), compared to reductions of up to half the frequency by VCS (27.2%) or qPCR.16S (22.6%). Infection frequencies were higher for SCM and conv.16S regarding HCFO but greater for CO concerning conv.gdh, such differences being statistically significant. Heterogeneous toxigenic profiles were found, including amplification with lok1/3 primers simultaneously with other PaLoc markers (tcdA, tcdB or tcdC). These findings correspond the first report regarding the differential detection of CDI using in vitro culture and molecular detection tests in Colombia, the circulation of CD having heterogeneous toxigenic profiles and molecular arrays which could affect the impact of CDI epidemiology. © 2018 Muñoz, Ríos-Chaparro, Herrera, Soto-De Leon, Birchenall, Pinilla, Pardo-Oviedo, Josa, Patarroyo and Ramírez.
dc.languageeng
dc.relationFrontiers in Microbiology, ISSN:1664-302X, Vol. 9 (2018)
dc.relationhttps://www.frontiersin.org/articles/10.3389/fmicb.2018.00074/full
dc.relationFrontiers in Microbiology
dc.relationVol. 9
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.sourceAllegranzi, B., Bagheri Nejad, S., Combescure, C., Graafmans, W., Attar, H., Donaldson, L., Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis (2011) Lancet, 377, pp. 228-241
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectClostridium Difficile Toxin A
dc.subjectClostridium Difficile Toxin B
dc.subjectMolecular Marker
dc.subjectPrimer Dna
dc.subjectRna 16S
dc.subjectClostridium Difficile Infection
dc.subjectColombia
dc.subjectControlled Study
dc.subjectDiarrhea
dc.subjectDisease Control
dc.subjectDna Extraction
dc.subjectFeces Analysis
dc.subjectGene Expression
dc.subjectGenetic Marker
dc.subjectHealth Care Facility
dc.subjectHuman
dc.subjectIn Vitro Study
dc.subjectPractice Guideline
dc.subjectReal Time Polymerase Chain Reaction
dc.titleNew insights into Clostridium Difficile (CD) infection in Latin America : Novel description of toxigenic profiles of diarrhea-associated to CD in Bogotá, Colombia
dc.typearticle


Este ítem pertenece a la siguiente institución